Hepatic Hemangioendothelioma: An update
Autor: | Priya Bhosale, Mayur Virarkar, Mohammed Saleh, Radwan Diab, Peeyush Bhargava, Melissa W. Taggart |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Hepatocellular carcinoma medicine.medical_treatment Review Lollipop sign Liver transplantation Metastatic carcinoma Halo sign 03 medical and health sciences 0302 clinical medicine Cholangiocarcinomas Angiosarcoma Medicine Tumor marker Epithelioid hemangioendotheliomas medicine.diagnostic_test business.industry Gastroenterology Magnetic resonance imaging medicine.disease Oncology Positron emission tomography 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Radiology medicine.symptom business |
Zdroj: | World Journal of Gastrointestinal Oncology |
ISSN: | 1948-5204 |
DOI: | 10.4251/wjgo.v12.i3.248 |
Popis: | Primary epithelioid hemangioendotheliomas of the liver (EHL) are rare tumors with a low incidence. The molecular background of EHL is still under investigation, with WWTR1-CAMPTA1 mutation may function as a tumor marker. Commonly, this tumor is misdiagnosed with angiosarcoma, cholangiocarcinomas, metastatic carcinoma, and hepatocellular carcinoma (sclerosing variant). Characteristic features on imaging modalities such as ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography/computed tomography guide in diagnosis and staging. The “halo sign” and the “lollipop sign” on computed tomography and magnetic resonance imaging are described in the literature. Currently, there are no standardized guidelines for treating EHL with treatment options are broad including: chemotherapy, ablation, surgery and liver transplantation with inconsistent results. |
Databáze: | OpenAIRE |
Externí odkaz: |